HUBBARD ROBERT GLENN 4

What Happened
Robert Glenn Hubbard, a director of MetLife, acquired 771 shares on 2026-03-10 at an imputed price of $70.60 per share, valued at $54,433. The transaction is reported as an award/acquisition (code A) and reflects deferred shares becoming payable under MetLife’s director deferred compensation arrangements.

Key Details

• Transaction date: 2026-03-10; Filing date: 2026-03-12 (Form 4 accession 0001283051-26-000005).
• Price and value: 771 shares × $70.60 = $54,433.
• Transaction type: A (award/acquisition) — imputed reinvestment of dividends on deferred shares.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: F1 states these are deferred shares (MetLife common stock that became payable but were deferred) credited via imputed dividend reinvestment under the MetLife Deferred Compensation Plan for Non-Management Directors.
• Timeliness: Filing appears timely (transaction reported two days after the trade date).

Context
This was not an open-market purchase but a crediting of deferred shares tied to the director compensation plan (dividend reinvestment). Such awards are administrative/compensation events and do not necessarily signal a trading decision or change in company outlook.